Benitec Biopharma Inc. (NASDAQ:BNTC) Financings

Benitec Biopharma Inc.

Financings

RaiseDate
Public offering of common stock
Update: US$13.5 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Nov 6, 2025
Registered direct offering of common stock
Update: US$13.5 a share · Leerink Partners +2
Dealers: Leerink Partners, TD Cowen, Evercore ISI
Buyers: Suvretta Capital (1,481,481 shares of common stock)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Nov 6, 2025
Public offering of common stock or pre-funded warrants
Announced: US$13 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Citizens Capital Markets
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Mar 25, 2025
Registered direct offering of common stock
Announced: US$13 a share
Buyers: Suvretta Capital (900,000 shares of common stock)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Mar 25, 2025

Read by 6ix AI from the company's releases